Miriam Hernangómez-Herrero

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

L. Mestre, C. Guaza, F. Correa, 2011, Brain, Behavior, and Immunity.

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors

J. Borrell, L. Mestre, C. Guaza, 2011, Journal of Neuroinflammation.